Neurocrine Biosciences
NBIX
#1438
Rank
$15.66 B
Marketcap
$155.80
Share price
3.46%
Change (1 day)
29.37%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Number of shares outstanding for Neurocrine Biosciences (NBIX)

Number of shares outstanding as of May 2026 : 100,500,000

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 100,500,000. At the end of 2026 the company had 100,500,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Neurocrine Biosciences from 1996 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.10 B0.6%
202599.9 M-0.1%
20240.10 B1.63%
202398.4 M2.18%
202296.3 M1.48%
202194.9 M1.5%
202093.5 M1.41%
201992.2 M1.61%
201890.74 M2.34%
201788.66 M2.06%
201686.87 M0.8%
201586.18 M13.19%
201476.13 M13.06%
201367.34 M1.42%
201266.4 M20.2%
201155.24 M0.74%
201054.84 M40.28%
200939.09 M1.69%
200838.44 M1.2%
200737.99 M0.32%
200637.86 M3.16%
200536.7 M0.77%
200436.42 M13.65%
200332.05 M5.02%
200230.52 M18.23%
200125.81 M17.18%
200022.03 M15.17%
199919.13 M5.22%
199818.18 M13.64%
199716 M-20%
199620 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Pfizer
PFE
5,691,000,000 5,562.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,768,762,377 1,659.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
893,500,000 789.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
56,354,000-43.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
24,492,000-75.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
20,686,000-79.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
2,539,632-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
443,628,000 341.42%๐Ÿ‡ฌ๐Ÿ‡ง UK